PrEP delivery in family planning clinics
Part of Immune system & allergy, Infections clinical trials.
This trial tests a program where HIV testing counselors help family planning patients learn about and get PrEP, a daily pill that prevents HIV. It aims to make PrEP easier to access in clinics you may already visit.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 15 years old or older.
- You get health services at one of the participating public health clinics.
- You do not already have HIV (based on your clinic records before your visit).
- You are interested in learning about ways to prevent HIV.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a “one-stop” support pathway meant to make it easier for PrEP clinics in Kenya to deliver PrEP care. It involves interviews with people using PrEP services and with healthcare and policy leaders who help run or guide PrEP delivery.
This study aims to expand access to PrEP (a daily pill that prevents HIV) for pregnant and postpartum women visiting maternal and child health clinics in Kenya. It also includes health care workers who provide PrEP services.
This study tests whether pharmacies can offer HIV prevention medications (PrEP/PEP) with remote nurse support. It aims to make HIV prevention easier to access in the community.
This study tests a counseling program to help women decide whether to use PrEP (a daily pill that prevents HIV). It aims to make PrEP choices easier and more informed in sexual and reproductive health clinics.
This study looks at offering HIV prevention medicines (PrEP) to patients visiting a family planning clinic. It aims to make it easier for people to access this care alongside their regular visit.
This study tests a counseling program to help more people who could benefit from PrEP (a pill that prevents HIV) actually start taking it. If you're a healthcare provider or someone looking for HIV prevention, this study might help improve access to PrEP.
Hear when a new HIV Pre-exposure Prophylaxis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.